Please login to the form below

Not currently logged in


This page shows the latest OHE news and features for those working in and with pharma, biotech and healthcare.

Pharma must engage on the affordability question, says ABPI

Pharma must engage on the affordability question, says ABPI

Professor Adrian Towse, director of the ABPI funded Office of Health Economics, (OHE) said that one of the main reasons was the need for a return on investment on pharma's

Latest news

  • UK lags behind other countries in use of branded drugs UK lags behind other countries in use of branded drugs

    The research by the Office of Health Economics (OHE) - which receives funding from the drug industry as well as other sources - says that the UK ranked ninth among 13 high-income

  • Orphan drug legislation hailed as success

    diseases. The assessment, commissioned from the Office of Health Economics (OHE) Consulting, reveals that between 2000 and 2004, R&D investment in rare diseases in Europe increased by more than half;

  • North-South divide?

    The October 2009 Office of Health Economics (OHE) report, Access Mechanisms for Orphan Drugs: a Comparative Study of Selected European Countries, states that, of 28 orphan medicines (prevalence < 5 per 10, ... The Scottish system does, therefore, have

  • New compendium reveals UK's health trends

    According to the OHE, in 2006, a generic prescription dispensed in England cost an average of GBP4.76, while a branded prescription cost am average of GBP19.35. ... Cancer. OHE statistics also show that cancer is continuing to become more prevalent, but

  • OFT recommends change to current drug pricing system

    Big Pharma reactsÖ. At a press conference called by the Association of the British Pharmaceutical Industry (ABPI) on 19 February, President Nigel Brooksby, Head of the OHE Professor Adrian Towse and

More from news
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Managing real world data governance Managing real world data governance

    In a study conducted by OHE Consulting, funded by Lilly, we analysed the current data governance arrangements in eight countries, and proposed an aspirational governance framework based on these analyses. ... is an economist at the Office of Health

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...